• How MJFF “De-Risks” PD Drug Development Pipeline

  • Jan 17 2024
  • Durée: 33 min
  • Podcast
Page de couverture de How MJFF “De-Risks” PD Drug Development Pipeline

How MJFF “De-Risks” PD Drug Development Pipeline

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • One key pillar of The Michael J. Fox Foundation’s research strategy is a focus on “de-risking" potential treatments for Parkinson’s disease. This episode of our award-winning “Parkinson’s Science POV” series explains how lowering the risk associated with developing new therapies leads to a more robust pipeline of treatments. The episode details several recent successes of the strategy.

    Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. https://apple.co/3p02Jw0

    Join a study today to help speed progress toward better treatments and a cure for Parkinson’s disease. To search for studies in your area, visit Fox Trial Finder at foxtrialfinder.org.

    Whether you have Parkinson’s or not, you can help move research forward. Join the study that’s changing everything. Find out more at michaeljfox.org/podcast-ppmi.

    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de How MJFF “De-Risks” PD Drug Development Pipeline

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.